AGM 2021

May 12, 2021

Good morning, everyone. Will the meeting please come to order? I'm Mark Ordan, Chief Executive Officer and a member of the Board of Directors of Med Nasdaq. Through the continued public health concerns resulting from the COVID-nineteen pandemic and to protect the health and safety of our shareholders, directors and employees, this year's annual meeting is being held in a virtual only meeting format. And Chief Financial Officer Doctor. Jay Andriana, Executive Vice President, General Counsel and Secretary for today's meeting John C. Peppier, Senior Vice President and Chief Accounting Officer and Doctor. Mack Hinson, President, Pediatrics and Obstetrics Medical Group. Charles Lynch and Meredith, along with us, will serve as inspectors for today's meeting. Notice that the meeting was given to shareholders of record on March 23, 2021. The record date for this meeting was March 10, 20 21. Holders of common stock on that date are entitled to 1 vote per share on each matter that is submitted to the company's shareholders for approval. The list of shareholders of record of the company as of the close of business on March 10, 2021, is available for inspection by the shareholders upon request. The inspectors of election have informed me that by more than a majority of the outstanding shares of common stock are present by proxy at this meeting. Therefore, a forum is present and I declare that this meeting is duly qualified to transact business. This meeting has been called to order to take action upon 1st, the election of 11 directors to serve until the next annual meeting of shareholders or until their respective successors are duly elected and qualified second, a proposal to approve the amendment and restatement of the company's amended and restated 2,008 incentive compensation plan 3rd, a proposal to approve the amendment and restatement of the company's 1996 non qualified employee stock purchase plan as amended, ratification of the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the 2021 year the approval on an advisory basis of the compensation for the company's named executive officers as disclosed in the company's proxy statements and finally to consider and act upon any other business that may properly come before the meeting and any adjournments thereof. The polls are now open for you to vote. If you previously voted by proxy, you do not need to vote again. If you are voting today, you must ensure you submit your electronic ballots in order for your votes to be counted. The Inspector elections will not accept votes submitted after the closing of the polls. Please note that any votes submitted via electronic ballot will be subject to final verification by the inspectors of elections. All shareholders attending or by proxy have now had a chance to vote, and the polls are declared closed. The inspectors have provided me with the preliminary voting results, and I report that the shareholders have elected all of the nominees to the Board of Directors, approved the amendment and restatement of the company's amended and restated 2,008 incentive compensation plan approved the amended and restatement of company's 1996 non qualified employee stock purchase plan as amended, ratify the appointment of PricewaterhouseCoopers as our public accounting firm and approve the compensation of our named executive officers. Is there any other business to come before this meeting today? If there's no other business, is there a motion to adjourn this meeting? So moved. Is there a second? Back in the second. Thank you. The business portion of the Annual Meeting of the Shareholders of MEDNAIC, Inc. For 2021 is now adjourned. At this time, we will be happy to answer any questions you may have. In addition to our officers and directors, please note that representatives of PricewaterhouseCoopers screen. It is possible that today's meeting, including some of our comments and some of our responses to your questions, may include forward looking statements that are based on certain assumptions and are subject to a number of risks and uncertainties, including risks and uncertainties that are included in the company's SEC reports, and we assume no responsibility for updating any forward looking statements. Are there any questions? No questions. There are no questions. So at this time, if there are no other questions, this meeting is now adjourned.